logo
Plus   Neg
Share
Email

Abbott Announces Availability Of FreeStyle Libre 2 ICGM System For Medicare Patients

Abbott (ABT) announced the company's next-generation FreeStyle Libre 2 integrated continuous glucose monitoring system is now available to Medicare patients. It is now accessible to all Medicare patients with diabetes who meet the eligibility criteria. Abbott noted that its FreeStyle Libre 2 system is priced 70% lower than other available continuous glucose monitoring devices.

The FreeStyle Libre 2 Flash Glucose Monitoring System is a continuous glucose monitoring device with real time alarms capability indicated for the management of diabetes in persons age 4 and older.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices. Shares of Daimler AG were gaining around 2 percent in the morning trading in Germany after the auto giant reported Friday higher profit in its third-quarter, despite weakness in revenues and sales volume. Further, the company now expects Group EBIT for full year 2020 at the prior-year level, compared to previous expectation of a decline. Retailer Bed Bath & Beyond Inc. is recalling SALT Lounge Chairs citing fall risks, the U.S. Consumer Product Safety Commission announced. The recall involves about 10,000 units sold in the United States and about 330 sold in Canada. The chairs were manufactured in China, and imported by Liberty Procurement Co. Inc., an affiliate of Bed Bath & Beyond.
Follow RTT